Roles of prostaglandins and leukotrienes in acute inflammation caused by bacterial infection

Current Opinion in Infectious Diseases

Volumn 14, Issue 3, 2001, Pages 257-263

  Yoshikai, Y ^a  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONATE 5 LIPOXYGENASE; ARACHIDONIC ACID; CYCLOPENTENONE; CYTOKINE; HISTAMINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LEUKOTRIENE; PHOSPHOLIPASE A2; PROSTAGLANDIN; PROSTAGLANDIN SYNTHASE; PROSTANOID; THROMBOXANE;

BACTERIAL INFECTION; BLOOD VESSEL PERMEABILITY; CYTOKINE PRODUCTION; ENZYME ACTIVATION; HUMAN; INFLAMMATION; LEUKOCYTE; OXYGENATION; PROTEIN EXPRESSION; REVIEW;

EID: 0035001045     PISSN: 09517375     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001432-200106000-00003     Document Type: Review

References (58)

1. Mediators of inflammation
2. Inhibitors and antagonists of cyclooxygenase, 5-lipooxygenase, and platelet activating factor
3. Arachidonic acid oxygeneration by COX-1 and COX-2. Mechanisms of catalysis and inhibition
4. Role and regulation of cyclooxygenase-2 during inflammation
5. The nature and composition of 15-deoxy-delta(12,14)PGJ(2)
6. Proetanoid receptors: Structures, properties, and functions
7. The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation
8. PPAR-γ agonists inhibit production of monocyte inflammatory cytokines
9. Activation of human T lymphocytes is inhibited by peroxisome proliferator-activated receptor gamma (PPAR-γ) agonists. PPAR-γ co-association with transcription factor NFAT
10. Leukotrienes and lipoxins: Structures, biosynthesis, and biological effects
11. Role of the 5-lipoxygenase -activating protein (FLAP) in murine acute inflammatory responses
12. Collagen-induced arthritis is reduced in 5-lipoxygenase-activating protein-deficient mice
13. In-situ amplification of 5-lipoxygenase and 5-lipoxygenase-activating protein in allergic airway inflammation and inhibition by leukotriene blockade
14. Determination of the contribution of cysteinyl leukotrienes and leukotriene B4 in acute inflammatory responses using 5-lipoxygenase- and leukotriene A4 hydrolase-deficient mice
15. Leukotriene C4 synthase, A pivotal enzyme in the biosynthesis of the cysteinyl leukotrienes
16. A second leukotriene B(4) receptor, BLT2. A new therapeutic target in inflammation and immunological disorders
17. Molecular cloning and characterization of another leukotriene B4 receptor
18. Novel hepatointestinal leukotriene B4 receptor. Cloning and functional characterization
19. The scent of a phagocyte: Advances on leukotriene B(4) receptors
20. The PPAR-γ-leukotriene B4 pathway to inflammation control
21. Characterization of the human cysteinyl leukotriene CysLT1 receptor
22. Identification, molecular cloning, expression, and characterization of a cysteinyl leukotriene receptor
23. Molecular cloning and characterization of a second human cysteinyl leukotriene receptor: Discovery of a subtype selective agonist
24. Characterization of the human cysteinyl leukotriene 2 receptor
25. Altered pain perception and inflammatory response in mice lacking prostacyclin receptor
26. Neutrophil-mediated changes in vascular permeability are inhibited by topical application of aspirin-triggered 15-epi-lipoxin A4 and novel lipoxin B4 stable analogues
27. Functional studies of leukotriene receptors in vascular tissues
28. Leukotriene bronchoconstriction induced by allergen and exercise
29. Binding to cysteinyl-leukotriene receptors
30. A G-protein-coupled receptor for leukotriene B4 that mediates chemotaxis
31. BLTR mediates leukotriene B(4)- induced chemotaxis and adhesion and plays a dominant role in eosinophil accumulation in a murine model of peritonitis
32. Targeted disruption of the leukotriene B(4) receptor in mice reveals its role in inflammation and platelet-activating factor-induced anaphylaxis
33. Chemoattractant receptors activate distinct pathways for chemotaxis and secretion. Role of G-protein usage
34. Leukotriene B4 receptor transgenic mice reveal novel protective roles for lipoxins and aspirin-triggered lipoxins in reperfusion
35. Leukotriene-deficient mice manifest enhanced lethality from Klebsiella pneumonia in association with decreased alveolar macrophage phagocytic and bactericidal activities
36. Role of mast cell leukotrienes in neutrophil recruitment and bacterial clearance in infectious peritonitis
37. Prostaglandin E2 stimulates AP-1-mediated CD14 expression in mouse macrophages via cyclic AMP-dependent protein kinase A
38. Critical roles of toll-like receptors in host defense
39. Gene expression of toll-like receptor 2, but not toll-like receptor 4, is induced by LPS and inflammatory cytokines in mouse macrophages
40. Prostaglandin E2 and dexamethasone inhibit IL-12 receptor expression and IL-12 responsiveness
41. Sensitivity difference to the suppressive effect of prostaglandin E2 among mouse strains: A possible mechanism to polarize Th2 type response in BALB/c mice
42. Prostaglandin E2 suppressed IL-15 mediated human NK cell function through downregulation of common γ-chain
43. Impaired febrile response in mice lacking the prostaglandin E receptor subtype EP3
44. Selective modulation of BV-2 microglial activation by prostaglandin E(2). Differential effects on endotoxin-stimulated cytokine induction
45. Prostaglandin E2 and tumor necrosis factor alpha cooperate to activate human dendritic cells: Synergistic activation of interleukin-12 production
46. Evidence for the involvement of interleukin-10 in the differential deactivation of murine peritoneal macrophages by prostaglandin E2
47. Prostaglandin E2 protects against liver injury after Escherichia coli infection but hampers the resolution of the infection in mice
48. Prostaglandin E(1) protects against liver injury induced by Escherichia coli infection via a dominant Th2-like response of liver T cells in mice
49. Prostaglandin-E2 is a potent inhibitor of human interleukin-12 production
50. RelA/p65 is a molecular target for the immunosuppressive action of protein kinase A
51. Inducible cyclooxygenase may have anti-inflammatory properties
52. Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IκB kinase
53. 15-Deoxy-δ12,14-prostaglandin J2 inhibits multiple steps in the NF-κB signaling pathway
54. Inhibition of IκB kinase and IκB phosphorylation by 15-deoxy-δ(12,14)-prostaglandin J(2) in activated murine macrophages
55. Contribution of cyclopentenone prostaglandins to the resolution of inflammation through the potentiation of apoptosis in activated macrophages
56. Cyclooxygenase 1 and 2
57. Cyclooxygenase in biology and disease
58. Impaired mucosal defense to acute colonic injury in mice lacking cyclooxygenase-1 or cyclooxygenase-2